Agios Pharm (AGIO) stock news · rev $54.0M
Agios Pharm (AGIO) is a biotechnology company listed on US.
This AGIO news page leads with what Agios Pharm filed — not a scraped headline mill.
No cached 8-K sentence for AGIO yet. We will not pad this page with generic market recap.
Latest reported AGIO revenue for 2025-12-31 was $54.0M. Net income was -$412.8M. Revenue was up 48.0% from 2024-12-31 to 2025-12-31. AGIO currently screens at market cap $1.68B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AGIO stock page; for the tape open the quote page.
AGIO stock news FAQ
What are AGIO's latest revenue and net income?
Latest cached Agios Pharm (AGIO) revenue for Dec 31, 2025 was $54.0M. Net income was -$412.8M. Statements: https://lician.com/financials/agio
How did AGIO revenue change from the prior cached period?
Cached Agios Pharm (AGIO) revenue was up 48.0% from $36.5M (Dec 31, 2024) to $54.0M (Dec 31, 2025). Statements: https://lician.com/financials/agio
What is AGIO's market cap?
Agios Pharm (AGIO) market cap is $1.68B on the latest cached fundamentals snapshot.
What kind of company is AGIO?
Agios Pharm (AGIO) is a biotechnology company listed on US.
Where is AGIO stock news listed?
Cached stock news for Agios Pharm (AGIO) is listed at https://lician.com/news/agio. Filings: https://lician.com/sec/agio
Not investment advice.